Bikul Das

4.5k total citations · 1 hit paper
54 papers, 3.3k citations indexed

About

Bikul Das is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bikul Das has authored 54 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Bikul Das's work include Cancer, Hypoxia, and Metabolism (13 papers), Cancer Cells and Metastasis (8 papers) and Epigenetics and DNA Methylation (8 papers). Bikul Das is often cited by papers focused on Cancer, Hypoxia, and Metabolism (13 papers), Cancer Cells and Metastasis (8 papers) and Epigenetics and DNA Methylation (8 papers). Bikul Das collaborates with scholars based in United States, India and Canada. Bikul Das's co-authors include Herman Yeger, Reza Bayat Mokhtari, Sushil Kumar, Narges Baluch, Tina S. Homayouni, Sylvain Baruchel, Rika Tsuchida, David Malkin, Gideon Koren and Dean W. Felsher and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Bikul Das

51 papers receiving 3.3k citations

Hit Papers

Combination therapy in combating cancer 2017 2026 2020 2023 2017 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bikul Das United States 23 1.6k 922 628 391 378 54 3.3k
Hsin‐Jung Li Taiwan 20 2.5k 1.5× 879 1.0× 523 0.8× 390 1.0× 451 1.2× 34 3.8k
Genevieve Housman United States 10 1.7k 1.1× 918 1.0× 665 1.1× 295 0.8× 186 0.5× 17 2.9k
Zhao Huang China 28 2.1k 1.3× 931 1.0× 1.2k 1.8× 507 1.3× 573 1.5× 60 4.1k
Gerd Bendas Germany 32 1.8k 1.1× 703 0.8× 359 0.6× 393 1.0× 329 0.9× 118 3.3k
Paul M. Loadman United Kingdom 37 2.1k 1.3× 1.1k 1.2× 865 1.4× 410 1.0× 234 0.6× 152 4.0k
Caitriona Holohan United Kingdom 13 2.6k 1.6× 1.3k 1.4× 823 1.3× 602 1.5× 326 0.9× 18 4.1k
Gennadi V. Glinsky United States 32 2.8k 1.7× 1.0k 1.1× 825 1.3× 329 0.8× 457 1.2× 75 4.1k
Mary Bebawy Australia 39 2.7k 1.7× 1.1k 1.2× 1.5k 2.4× 458 1.2× 306 0.8× 81 4.8k
Giuseppe Corona Italy 30 1.7k 1.0× 1.1k 1.2× 503 0.8× 434 1.1× 133 0.4× 109 3.0k
Sarah Heerboth United States 11 2.0k 1.3× 983 1.1× 710 1.1× 318 0.8× 211 0.6× 14 3.2k

Countries citing papers authored by Bikul Das

Since Specialization
Citations

This map shows the geographic impact of Bikul Das's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bikul Das with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bikul Das more than expected).

Fields of papers citing papers by Bikul Das

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bikul Das. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bikul Das. The network helps show where Bikul Das may publish in the future.

Co-authorship network of co-authors of Bikul Das

This figure shows the co-authorship network connecting the top 25 collaborators of Bikul Das. A scholar is included among the top collaborators of Bikul Das based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bikul Das. Bikul Das is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hong, et al.. (2025). Hypoxia-driven mobilization of altruistic cancer stem cells in platinum-treated head and neck cancer. Frontiers in Immunology. 15. 1336882–1336882. 2 indexed citations
2.
3.
Das, Bikul, et al.. (2023). Abstract 648: Oral microbiome reprograms oral cancer stem cells to the highly immunosuppressive tumor stemness defense (TSD) phenotype. Cancer Research. 83(7_Supplement). 648–648. 1 indexed citations
4.
Ramana, Chilakamarti V. & Bikul Das. (2022). Regulation of Lysosomal Associated Membrane Protein 3 (LAMP3) in Lung Epithelial Cells by Coronaviruses (SARS-CoV-1/2) and Type I Interferon Signaling. SHILAP Revista de lepidopterología. 10(1). 167–183. 2 indexed citations
5.
Mokhtari, Reza Bayat, et al.. (2022). Targeting hypoxia-induced tumor stemness by activating pathogen-induced stem cell niche defense. Frontiers in Immunology. 13. 933329–933329. 10 indexed citations
6.
Ramana, Chilakamarti V. & Bikul Das. (2021). Profiling transcription factor sub-networks in type I interferon signaling and in response to SARS-CoV-2 infection. SHILAP Revista de lepidopterología. 9(1). 273–288. 2 indexed citations
7.
Ramana, Chilakamarti V. & Bikul Das. (2021). Regulation of early growth response-1 (Egr-1) gene expression by Stat1-independent type I interferon signaling and respiratory viruses. SHILAP Revista de lepidopterología. 9(1). 289–303. 2 indexed citations
8.
Yeger, Herman, et al.. (2021). Coronavirus Activates an Altruistic Stem Cell–Mediated Defense Mechanism that Reactivates Dormant Tuberculosis. American Journal Of Pathology. 191(7). 1255–1268. 32 indexed citations
9.
Das, Bikul, et al.. (2021). Initiation of Post-Primary Tuberculosis of the Lungs: Exploring the Secret Role of Bone Marrow Derived Stem Cells. Frontiers in Immunology. 11. 594572–594572. 10 indexed citations
10.
Gogoi, Gayatri, et al.. (2019). Abstract 1614: Coconut kernel extract as a novel chemopreventive agent that target cancer stemness. Cancer Research. 79(13_Supplement). 1614–1614. 1 indexed citations
11.
Mokhtari, Reza Bayat, Narges Baluch, Sushil Kumar, et al.. (2019). Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane. BMC Cancer. 19(1). 864–864. 16 indexed citations
12.
Daifalla, Nada, et al.. (2016). CD271+ Mesenchymal Stem Cells as a Possible Infectious Niche for Leishmania infantum. PLoS ONE. 11(9). e0162927–e0162927. 14 indexed citations
13.
Das, Bikul, Suely Sanae Kashino, Deepjyoti Kalita, et al.. (2013). CD271 + Bone Marrow Mesenchymal Stem Cells May Provide a Niche for Dormant Mycobacterium tuberculosis. Science Translational Medicine. 5(170). 170ra13–170ra13. 147 indexed citations
14.
Das, Bikul, et al.. (2010). SBDS-deficiency results in deregulation of reactive oxygen species leading to increased cell death and decreased cell growth. Pediatric Blood & Cancer. 55(6). 1138–1144. 42 indexed citations
15.
Das, Bikul, Roula Antoon, Rika Tsuchida, et al.. (2008). Squalene Selectively Protects Mouse Bone Marrow Progenitors Against Cisplatin and Carboplatin-Induced Cytotoxicity In Vivo Without Protecting Tumor Growth. Neoplasia. 10(10). 1105–IN4. 79 indexed citations
16.
Forooghian, Farzin & Bikul Das. (2007). Anti-Angiogenic Effects of Ribonucleic Acid Interference Targeting Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor-1α. American Journal of Ophthalmology. 144(5). 761–768. 42 indexed citations
17.
Das, Bikul, Herman Yeger, & Sylvain Baruchel. (2006). Squalene protects mice bone marrow hematopoietic and mesenchymal stem cells against high-dose cisplatin in vivo by restoring antioxidant balance: implications in cancer chemotherapy. Cancer Research. 66. 266–266. 1 indexed citations
19.
Gee, M., Rika Tsuchida, Claudia Eichler-Jonsson, et al.. (2005). Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Oncogene. 24(54). 8025–8037. 73 indexed citations
20.
Das, Bikul, et al.. (2003). In vitro cytoprotective activity of squalene on a bone marrow versus neuroblastoma model of cisplatin-induced toxicity. European Journal of Cancer. 39(17). 2556–2565. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026